Shares of other companies:
April 29, 2024 Tesla, Baidu Join Forces for Self-Driving Tech in China
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Amazon Q1 Review: Best Of Big Tech Bunch
April 30, 2024
Tesla Q1: Facing A Liquidity Crunch; Dilution Ahead?
April 29, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
TEVA Stock News and Mentions of Teva Pharmaceutical Industries Lim. (TEVA) Stocktwits
Updated: April 30, 2024 (10:17)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Teva Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Teva Pharmaceutical Industries Lim. (TEVA) (TEVA).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Teva stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Teva Pharmaceutical Industries Lim. (TEVA) (TEVA)
April 30, 2024 (14:26) / "Stocknews.com" (by StockNews.com Staff)
GSK: 3 Top Pharma Stocks for May 2024
GSK: 3 Top Pharma Stocks for May ...
In Article Trend: Somewhat-Bullish
April 30, 2024 (08:00) / "GlobeNewswire" (by Alvotech)
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® ( adalimumab )
REYKJAVIK, ICELAND, PARSIPPANY, N.J., and TEL AVIV, ISRAEL ( April 30, 2024 ) - Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical ...
In Article Trend: Somewhat-Bullish
April 30, 2024 (08:00) / "GlobeNewswire" (by Alvotech)
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® ( adalimumab )
REYKJAVIK, Iceland and PARSIPPANY, N.J. and TEL AVIV, Israel, April 30, 2024 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of ...
In Article Trend: Somewhat-Bullish
April 24, 2024 (08:00) / "GlobeNewswire" (by Alvotech)
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® ( golimumab )
Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive topline results from a confirmatory clinical study for AVT05, Alvotech's proposed biosimilar to Simponi® and Simponi Aria® ...
In Article Trend: Neutral
April 22, 2024 (18:37) / "Benzinga" (by Vandana Singh)
US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz - Vanda Pharma ( NASDAQ:VNDA )
The U.S. Supreme Court has reportedly chosen not to review Vanda Pharmaceuticals Inc's VNDA attempt to revive patents for its sleep-disorder medication Hetlioz, which had previously been invalidated in a legal battle with generic drugmakers Teva Pharmaceutical Industries Limited TEVA and Apotex.
In Article Trend: Somewhat-Bullish
April 19, 2024 (10:10) / "GlobeNewswire" (by Alvotech)
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® ( adalimumab )
Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today a long-term agreement with a strategic partner to further enhance access to Adalimumab-ryvk in the U.S. market, the newly U.S.
In Article Trend: Somewhat-Bullish
April 19, 2024 (10:10) / "GlobeNewswire" (by Alvotech)
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® ( adalimumab )
REYKJAVIK, Iceland, April 19, 2024 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today a long-term agreement with a strategic partner to further enhance access ...
In Article Trend: Somewhat-Bullish
April 16, 2024 (21:30) / "GlobeNewswire" (by Alvotech)
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ ( ustekinumab-aekn ) , biosimilar to Stelara® ( ustekinumab )
REYKJAVIK, Iceland and PARSIPPANY, N.J., April 16, 2024 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. ( NYSE and TASE: TEVA ) , today announced that the U.S. Food and Drug Administration ( FDA ) has approved ...
In Article Trend: Neutral
April 16, 2024 (21:30) / "GlobeNewswire" (by Alvotech)
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ ( ustekinumab-aekn ) , biosimilar to Stelara® ( ustekinumab )
REYKJAVIK, ICELAND & PARSIPPANY, NJ - Alvotech ( NASDAQ: ALVO ) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. ( NYSE and TASE: TEVA ) , today announced that the U.S. Food and Drug Administration ( FDA ) has approved SELARSDI ( ustekinumab-aekn ) injection for ...
In Article Trend: Neutral
April 3, 2024 (11:41) / "Benzinga" (by Globe Newswire)
Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024 - Alvotech ( NASDAQ:ALVO )
REYKJAVIK, Iceland, April 03, 2024 ( GLOBE NEWSWIRE ) -- Alvotech ALVO, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will host an audio call with a market update at 12:15 pm GMT / 08:15 am EDT on ...
In Article Trend: Somewhat-Bullish
April 3, 2024 (11:41) / "GlobeNewswire" (by Alvotech)
Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024
REYKJAVIK, Iceland, April 03, 2024 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will host an audio call with a market update at 12:15 pm GMT / ...
In Article Trend: Neutral
April 3, 2024 (10:43) / "GlobeNewswire" (by Alvotech)
Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024
Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will host an audio call with a brief market update at 12:15 pm GMT / 08:15 am EDT. Anil Okay, Chief Commercial Officer, ...
In Article Trend: Neutral
April 3, 2024 (09:21) / "Motley Fool" (by Sean Williams)
3 No-Brainer Stocks to Buy With $600 Right Now
A relatively modest amount of money can go a long way when it's put to work in top-tier businesses with abundant catalysts.
In Article Trend: Somewhat-Bullish
March 28, 2024 (09:23) / "Zacks Commentary" (by Zacks Equity Research)
Bausch ( BHC ) Soars 6.4%: Is Further Upside Left in the Stock?
Bausch (BHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
In Article Trend: Somewhat-Bullish
March 27, 2024 (19:30) / "Benzinga" (by Benzinga Insights)
Spotlight on Teva Pharmaceutical Indus: Analyzing the Surge in Options Activity - Teva Pharmaceutical Indus ( NYSE:TEVA )
Whales with a lot of money to spend have taken a noticeably bearish stance on Teva Pharmaceutical Indus. Looking at options history for Teva Pharmaceutical Indus TEVA we detected 8 trades.
In Article Trend: Somewhat-Bullish
March 25, 2024 (13:05) / "Benzinga" (by Avi Kapoor)
Jim Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In' - ARM Holdings ( NASDAQ:ARM ) , Comstock Resources ( NYSE:CRK )
Raymond James Financial, Inc. RJF is now valued more highly than JPMorgan Chase & Co. JPM, according to Jim Cramer. "So, I'm going to have to say, it's too late, we missed it," he said. "Let's find the next one."
In Article Trend: Somewhat-Bullish
March 22, 2024 (20:15) / "GlobeNewswire" (by Alvotech)
Alvotech Announces Increase in Number of Own Shares
Alvotech ( NASDAQ: ALVO ) ( the "Company" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, has increased the Company´s share capital by an amount of one hundred and thirty thousand ( USD 130,000 ) by issuing thirteen ...
In Article Trend: Somewhat-Bullish
March 22, 2024 (20:15) / "GlobeNewswire" (by Alvotech)
Alvotech Announces Increase in Number of Own Shares
REYKJAVIK, Iceland, March 22, 2024 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) ( the "Company" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, has increased the Company´s share capital by an amount of one hundred ...
In Article Trend: Somewhat-Bullish
March 22, 2024 (16:18) / "PR Newswire"
Pharmaceuticals Market In Germany size is set to grow by USD 21.44 bn from 2023-2027, Abbott Laboratories, AbbVie ... - PR Newswire
Pharmaceuticals Market In Germany size is set to grow by USD 21.44 bn from 2023-2027, Abbott Laboratories, AbbVie ... PR ...
In Article Trend: Somewhat-Bullish
March 21, 2024 (11:17) / "Benzinga" (by Vandana Singh)
Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Month - GSK ( NYSE:GSK )
On Wednesday, GSK Plc GSK announced it will cap out-of-pocket costs for eligible patients at no more than $35 per month for all its asthma and chronic obstructive pulmonary disease ( COPD ) medicines. The program will be implemented by January 1, 2025.
In Article Trend: Neutral
March 20, 2024 (20:15) / "GlobeNewswire" (by Alvotech)
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Alvotech ( NASDAQ: ALVO, or the "Company" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for full year 2023 and provided a summary of recent pipeline and corporate highlights.
In Article Trend: Neutral
March 20, 2024 (20:15) / "GlobeNewswire" (by Alvotech)
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
REYKJAVIK, Iceland, March 20, 2024 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO, or the "Company" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for full year 2023 and provided a ...
In Article Trend: Neutral
March 12, 2024 (14:20) / "Benzinga" (by Globe Newswire)
Global Contraceptive Drugs Market Size is Projected to Reach USD 28.96 billion by 2030, Growing at a CAGR of 7.3%: Straits Research - Agile Therapeutics ( NASDAQ:AGRX ) , GSK ( NYSE:GSK )
New York, United States, March 12, 2024 ( GLOBE NEWSWIRE ) -- Contraception encompasses the use of drugs to prevent pregnancy, the transmission of sexually transmitted diseases ( STDs ) , the transmission of sexually transmitted infections ( STIs ) , family planning, and birth control.
In Article Trend: Somewhat-Bullish
March 6, 2024 (12:01) / "Benzinga" (by Globe Newswire)
iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors - ITeos Therapeutics ( NASDAQ:ITOS )
WATERTOWN, Mass. and GOSSELIES, Belgium, March 06, 2024 ( GLOBE NEWSWIRE ) -- iTeos Therapeutics, Inc.
In Article Trend: Neutral
March 6, 2024 (12:01) / "GlobeNewswire" (by iTeos Therapeutics Inc.)
iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
WATERTOWN, Mass. and GOSSELIES, Belgium, March 06, 2024 ( GLOBE NEWSWIRE ) -- iTeos Therapeutics, Inc. ( Nasdaq: ITOS ) , a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced the ...
In Article Trend: Neutral
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website